Invenomic Capital Management’s Accendra Health ACH Stock Holding History

Invenomic Capital Management’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.62M	Sell	2,812,474 -556,501	-17%	-$1.73M	0.57%	63
2026 Q1	$7.68M	Sell	3,368,975 -133,370	-4%	-$307K	0.35%	77
2025 Q4	$9.81M	Buy	3,502,345 +753,223	+27%	+$2.69M	0.46%	72
2025 Q3	$13.2M	Buy	+2,749,122	New	+$17.5M	0.64%	57
2020 Q3	–	Sell	-71,489	Closed	-$545K	–	171
2020 Q2	$545K	Sell	71,489 -165,955	-70%	-$1.21M	0.4%	75
2020 Q1	$2.17M	Buy	+237,444	New	+$1.43M	1.78%	14

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DIA

Dana Investment Advisors Waukesha, Wisconsin $3.84B AUM 38.84% 1-Year Est. Return

Invenomic Capital Management's ACH Position: Q2 2026 in Review

Invenomic Capital Management reduced its Accendra Health (ACH) stake by 17% in Q2 2026, selling an estimated $1.73M and leaving 2,812,474 shares worth $9.62M. The position accounts for 0.57% of the portfolio, ranked #63.

Invenomic Capital Management first reported a position in ACH in Q1 2020 and has held it in 6 quarters since. The position peaked at $13.2M in Q3 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

Invenomic Capital Management held 2,812,474 shares of Accendra Health worth $9.62M as of Q2 2026.
Invenomic Capital Management sold 556,501 Accendra Health shares in Q2 2026, an estimated $1.73M.
Accendra Health made up 0.57% of Invenomic Capital Management's portfolio in Q2 2026, its #63 holding.
Invenomic Capital Management first reported a position in Accendra Health in Q1 2020 and has held it in 6 quarters since.
Invenomic Capital Management's Accendra Health position peaked at $13.2M in Q3 2025.
139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.